BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 8061379)

  • 41. Acute renal allograft rejection: diagnostic significance of focal peritubular capillary C4d.
    Kayler LK; Kiss L; Sharma V; Mohanka R; Zeevi A; Girnita A; Shapiro R; Randhawa PS
    Transplantation; 2008 Mar; 85(6):813-20. PubMed ID: 18360261
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Banff schema for grading liver allograft rejection: utility in clinical practice.
    Ormonde DG; de Boer WB; Kierath A; Bell R; Shilkin KB; House AK; Jeffrey GP; Reed WD
    Liver Transpl Surg; 1999 Jul; 5(4):261-8. PubMed ID: 10388498
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fibrosis-associated gene expression in renal transplant glomeruli after acute renal allograft rejection.
    Brook NR; White SA; Waller JR; Bicknell GR; Nicholson ML
    Br J Surg; 2003 Aug; 90(8):1009-14. PubMed ID: 12905557
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of the Banff criteria for the histological diagnosis of rejection in renal allograft biopsies.
    Dooper MM; Hoitsma AJ; Koene RA; Bogman MJ
    Transplant Proc; 1995 Feb; 27(1):1005-6. PubMed ID: 7878778
    [No Abstract]   [Full Text] [Related]  

  • 45. The role of C4d immunostaining in the evaluation of the causes of renal allograft dysfunction.
    Ranjan P; Nada R; Jha V; Sakhuja V; Joshi K
    Nephrol Dial Transplant; 2008 May; 23(5):1735-41. PubMed ID: 18065805
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Evolution of the classification of acute and chronic transplant rejection].
    Santoro D; Bellinghieri G; Mallamace A; Savica V
    G Ital Nefrol; 2005; 22 Suppl 33():S65-70. PubMed ID: 16419009
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinicopathologic correlations in acute renal graft rejection].
    Pizzolitto S; Boscutti G; Falconieri G; Montanaro D
    G Ital Nefrol; 2004; 21 Suppl 26():S19-27. PubMed ID: 15732040
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The dual role of epithelial-to-mesenchymal transition in chronic allograft injury in pediatric renal transplantation.
    Vitalone MJ; Naesens M; Sigdel T; Li L; Hseih S; Sarwal MM
    Transplantation; 2011 Oct; 92(7):787-95. PubMed ID: 21952304
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The extent of peritubular CD14 staining in renal allografts as an independent immunohistological marker for acute rejection.
    Dooper IM; Hoitsma AJ; Maass CN; Assmann KJ; Tax WJ; Koene RA; Bogman MJ
    Transplantation; 1994 Oct; 58(7):820-7. PubMed ID: 7524205
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reproducibility of the Banff schema in reporting protocol biopsies of stable renal allografts.
    Gough J; Rush D; Jeffery J; Nickerson P; McKenna R; Solez K; Trpkov K
    Nephrol Dial Transplant; 2002 Jun; 17(6):1081-4. PubMed ID: 12032200
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Banff classification of renal allograft pathology: where do we go from here?
    Racusen LC; Rayner DC; Trpkov K; Olsen S; Solez K
    Transplant Proc; 1995 Oct; 27(5):2561-3. PubMed ID: 7482825
    [No Abstract]   [Full Text] [Related]  

  • 52. Pathogenesis of tubulointerstitial fibrosis in chronic allograft dysfunction.
    Strutz F
    Clin Transplant; 2009 Dec; 23 Suppl 21():26-32. PubMed ID: 19930313
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Report of the Third Banff Conference on Allograft Pathology (July 20-24, 1995) on classification and lesion scoring in renal allograft pathology.
    Solez K; Benediktsson H; Cavallo T; Croker B; Demetris AJ; Drachenberg C; Emancipator S; Furness PN; Gaber LW; Gibson IW; Gough J; Gupta R; Halloran P; Häyry P; Kashgarian M; Marcussen N; Massy ZA; Mihatsch MJ; Morozumi K; Noronha I; Olsen S; Papadimitriou J; Paul LC; Picken M; Racusen LC; Ramos EL; Randhawa P; Rayner DC; Rush D; Sanfilippo F; Taskinen E; Trpkov K; Truong L; Yamaguchi Y; Yilmaz S
    Transplant Proc; 1996 Feb; 28(1):441-4. PubMed ID: 8644308
    [No Abstract]   [Full Text] [Related]  

  • 54. Unique changes in interstitial extracellular matrix composition are associated with rejection and cyclosporine toxicity in human renal allograft biopsies.
    Abrass CK; Berfield AK; Stehman-Breen C; Alpers CE; Davis CL
    Am J Kidney Dis; 1999 Jan; 33(1):11-20. PubMed ID: 9915262
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of histological damage on long-term kidney transplant outcome.
    Nankivell BJ; Fenton-Lee CA; Kuypers DR; Cheung E; Allen RD; O'Connell PJ; Chapman JR
    Transplantation; 2001 Feb; 71(4):515-23. PubMed ID: 11258430
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chronic allograft nephropathy or interstitial fibrosis and tubular atrophy: what is in a name?
    Haas M
    Curr Opin Nephrol Hypertens; 2014 May; 23(3):245-50. PubMed ID: 24626060
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of lesions indicating rejection in kidney transplant biopsies: tubulitis is severely under-detected by conventional microscopy.
    Elshafie M; Furness PN
    Nephrol Dial Transplant; 2012 Mar; 27(3):1252-5. PubMed ID: 21862457
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pathology of kidney transplant rejection.
    Solez K; Battaglia D; Fahmy H; Trpkov K
    Curr Opin Nephrol Hypertens; 1993 Nov; 2(6):904-11. PubMed ID: 7922231
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Injury and progressive loss of peritubular capillaries in the development of chronic allograft nephropathy.
    Ishii Y; Sawada T; Kubota K; Fuchinoue S; Teraoka S; Shimizu A
    Kidney Int; 2005 Jan; 67(1):321-32. PubMed ID: 15610258
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nonrejection pathology of renal allograft biopsies: 10 years experience from a tertiary care center in north India.
    Philip KJ; Calton N; Pawar B
    Indian J Pathol Microbiol; 2011; 54(4):700-5. PubMed ID: 22234094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.